Treating Stage 3 Lung Cancer

This content is created by Healthgrades and brought to you by an advertising sponsor. More

This content is created or selected by the Healthgrades editorial team and is funded by an advertising sponsor. The content is subject to the Healthgrades medical review process for accuracy, balance and objectivity. The content is not edited or otherwise influenced by the advertisers appearing on this page except with the possible suggestion of the broad topic area. For more information, read the Healthgrades advertising policy.

Pneumonitis and Stage 3 Lung Cancer: A Side Effect of Chemo, Radiation, and Immunotherapy

Was this helpful?

If you have stage 3 lung cancer, you likely already know all lung cancer treatments have potential risks and side effects. Though your doctor will try to minimize their occurrence, it’s important to understand how to recognize treatment side effects should they develop. One possible, and potentially serious, side effect of lung cancer treatment is pneumonitis, a condition characterized by inflammation in your lungs. Certain substances, such as chemicals you breathe in or medications you take, can cause the air sacs in your lungs to become irritated and inflamed. This makes it hard for your lungs to enrich your blood with oxygen, leading to symptoms such as shortness of breath, dry cough, weakness, fatigue, fever, and weight loss.

Pneumonia is actually a type of pneumonitis. But often, pneumonia is used to refer to inflammation in your lungs caused by a viral or bacterial infection, while pneumonitis is used to describe lung inflammation that’s not related to an infection.

Taking Care of Yourself While Fighting Cancer

Which stage 3 lung cancer treatments can cause pneumonitis?

Some of the commonly used stage 3 lung cancer treatments—radiation, chemotherapy, and immunotherapy—can lead to pneumonitis as an adverse effect. Radiation therapy aims high-powered beams at your chest to kill cancer cells and shrink tumors, but it can also damage healthy tissue around it, causing inflammation.

Similarly, chemotherapy is used to destroy fast-growing stage 3 lung cancer cells. These strong drugs can impair normal lung cells as well, leading to inflammation and breathing problems. And immunotherapy, which boosts your immune system’s ability to fight cancer, can sometimes mount an unintended attack on the noncancerous cells in your lungs; this also brings inflammation.

Pneumonitis can be tricky to diagnose since it may not develop until months after your cancer treatment and can mimic other lung conditions (even lung cancer itself). But if pneumonitis goes unrecognized or untreated, it can cause permanent lung damage, called pulmonary fibrosis. So, it’s important to let your doctor know if you develop any symptoms to avoid further complications.

How is pneumonitis treated?

Since pneumonitis can range in severity from mild to life-threatening, treatment can vary. You may be prescribed corticosteroids to help reduce the inflammation in your lungs. Supplemental oxygen may be needed in some cases to make breathing easier. Medication to ease your coughing and help open up your airways may be given as well.

Your doctor may also temporarily pause your lung cancer treatment until your symptoms improve. Very significant pneumonitis may require your cancer treatment to be changed or stopped altogether.

Most cases of pneumonitis will resolve with treatment, but for some, it can have long-lasting effects on breathing and lung function.  

What factors increase the risk of pneumonitis from stage 3 lung cancer treatments?

We know some people have a higher risk of developing pneumonitis. Associated factors include:

  • Combination of radiation and chemotherapy as cancer treatment

  • Certain chemotherapy drugs, such as paclitaxel (Taxol) or docetaxel (Taxotere)

  • Co-existing lung disease, including emphysema and chronic obstructive pulmonary disorder (COPD)

  • High doses of radiation

  • Large areas of tissue exposed to radiation

Researchers are also studying whether certain genetic and molecular markers can be identified in patients who are more likely to develop pneumonitis.
Armed with this knowledge, we are learning how to more safely administer lung cancer treatments while minimizing side effects. For example, newer methods of radiation therapy, such as intensity-modulated radiation therapy, deliver precise radiation to the tumor with less exposure to normal tissue. Better identification of high-risk individuals can help guide future treatment decisions as well.

Was this helpful?
Medical Reviewer: William C. Lloyd III, MD, FACS
Last Review Date: 2020 Jan 28
  1. Characteristics and
    Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in
    Patients with Advanced Non-Small-Cell Lung Cancer. PLoS One.
  2. Drug-Related
    Pneumonitis in the Era of Precision Cancer Therapy. JCO Precision Oncology.
  3. How Radiation
    Affects Different Parts of the Body. American Cancer Society.
  4. Immunotherapy Side
    Effect: Pneumonitis. OncoLink.
  5. Nondosimetric Risk
    Factors for Radiation-Induced Lung Toxicity. Seminars in Radiation Oncology.
  6. Pneumonitis. Mayo
  7. Radiation Pneumonitis: Old
    Problem, New Tricks. Cancers.
What Forms of Self-Care Help You During Lung Cancer Treatment?
Male friends
Spending time with friends
Lady Walking
Woman reading book on sofa
Reading a good book
Spending time with friends
Reading a good book
You Might Also Like